1545-BQ10 202404 Unified Agenda of Federal Regulatory and Deregulatory Actions 1545 Internal Revenue Service IRS 1500 Department of the Treasury TREAS Prescription Drug and Health Care Spending (Temporary Regulation)

This rule implements the prescription drug reporting requirements that apply to group health plans and health insurance issuers offering coverage in the group and individual markets under section 204 of title II of Division BB of the Consolidated Appropriations Act of 2021.

]]> Other Significant Previously Published in The Unified Agenda Final Rule Stage No Undetermined 26 CFR 54.9825-1T 26 CFR 54.9825-2T 26 CFR 54.9825-3T 26 CFR 54.9825-4T 26 CFR 54.9825-5T 26 CFR 54.9825-6T ... 26 U.S.C. 7805 Pub. L. 116-260, Division BB, Title I and Title II No Request for Information (RFI) 06/23/2021 86 FR 32813 RFI Comment Period End 07/23/2021 Temporary Rule: TD 9968 11/23/2021 86 FR 66662 Temporary Rule Comment Period End 01/24/2022 Final Action 11/00/2024 REG-109378-21 (Interim Final Rule) Drafter attorney: Christopher Dellana (202) 317-5500 Reviewer attorney: Kevin Knopf (202) 317-5500 Treasury attorney: Linda Mendel (202) 921-8753 CC:EEE Undetermined Local State Yes No No No Christopher Dellana Attorney 1545 Internal Revenue Service IRS 202 317-4726 855 592-9846 christopher.j.dellana@irscounsel.treas.gov 111 Constitution Avenue NW, Room 5710, Washington DC 20224